EVI2B Antikörper (AA 22-202)
-
- Target Alle EVI2B Antikörper anzeigen
- EVI2B (Ecotropic Viral Integration Site 2B (EVI2B))
-
Bindungsspezifität
- AA 22-202
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser EVI2B Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Neutralization (Neut)
- Aufreinigung
- purified
- Immunogen
- Purified recombinant fragment of human CD361 (AA: extra 22-202) expressed in E. coli.
- Klon
- 8F3D1
- Isotyp
- IgG1
-
-
- Applikationshinweise
- ELISA: 1:10000, WB: 1:500 - 1:2000, FCM: 1:200 - 1:400, ICC: N/A, IHC: N/A
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- Purified antibody in PBS with 0.05 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- 4°C, -20°C for long term storage
-
- Target
- EVI2B (Ecotropic Viral Integration Site 2B (EVI2B))
- Andere Bezeichnung
- CD361 (EVI2B Produkte)
- Synonyme
- CD361 antikoerper, D17S376 antikoerper, EVDB antikoerper, Evi-2 antikoerper, Evi2 antikoerper, EVI2B antikoerper, ecotropic viral integration site 2B antikoerper, ecotropic viral integration site 2b antikoerper, EVI2B antikoerper, Evi2b antikoerper
- Hintergrund
-
Description: EVI2B is required for granulocyte differentiation and functionality of hematopoietic progenitor cells through the control of cell cycle progression and survival of hematopoietic progenitor cells.
Aliases: EVI2B, EVDB, D17S376
- Molekulargewicht
- 48.7 kDa
- Gen-ID
- 2124
-